Catalogo dei prodotti della ricerca

POZZILLI, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.982
EU - Europa 4.410
AS - Asia 2.969
SA - Sud America 106
AF - Africa 59
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 3
Totale 26.548
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.855
IT - Italia 1.442
SG - Singapore 1.228
IN - India 958
UA - Ucraina 694
SE - Svezia 666
CN - Cina 596
FI - Finlandia 485
DE - Germania 261
GB - Regno Unito 161
RU - Federazione Russa 141
IE - Irlanda 125
CA - Canada 108
BG - Bulgaria 103
AR - Argentina 91
NL - Olanda 75
ID - Indonesia 65
RO - Romania 64
AT - Austria 45
BE - Belgio 38
FR - Francia 30
TG - Togo 28
IR - Iran 20
CH - Svizzera 18
TR - Turchia 18
HK - Hong Kong 15
MX - Messico 15
EG - Egitto 14
IL - Israele 13
AU - Australia 12
TW - Taiwan 12
PL - Polonia 10
LT - Lituania 9
DK - Danimarca 8
BR - Brasile 7
CZ - Repubblica Ceca 7
IQ - Iraq 7
NZ - Nuova Zelanda 7
ZA - Sudafrica 7
KR - Corea 5
LB - Libano 5
MA - Marocco 5
CL - Cile 4
ES - Italia 4
GR - Grecia 4
HU - Ungheria 4
KZ - Kazakistan 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
EU - Europa 3
PA - Panama 3
PK - Pakistan 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
JP - Giappone 2
LK - Sri Lanka 2
LV - Lettonia 2
PE - Perù 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
BZ - Belize 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
Totale 26.548
Salva come PNG Salva come JPEG
Città #
Fairfield 3.359
Woodbridge 1.569
Ashburn 1.408
Chandler 1.332
Houston 1.229
Seattle 1.179
Cambridge 1.086
Wilmington 998
Singapore 890
Ann Arbor 626
Princeton 622
Plano 431
San Paolo di Civitate 403
Rome 394
Boston 312
Santa Clara 291
Lawrence 285
Beijing 282
Jacksonville 251
Dearborn 237
Des Moines 233
San Diego 232
Norwalk 149
Millbury 148
Andover 134
Dublin 121
Helsinki 111
Sofia 102
Federal 89
Boardman 87
Milan 76
New York 74
Falls Church 71
Toronto 67
Fasano 64
Jakarta 63
Moscow 58
Vienna 40
Bühl 39
Falkenstein 39
Hefei 37
Brussels 36
Mannheim 34
Los Angeles 31
Saint Petersburg 31
Nanjing 30
Lomé 28
London 28
San Mateo 26
Ottawa 25
Enschede 24
Guangzhou 18
Naples 18
Amsterdam 17
Bremen 17
Jinan 17
Florence 15
Hong Kong 15
Kunming 15
Munich 15
Nanchang 15
Redmond 14
Bern 13
Phoenix 13
Redwood City 12
Taipei 12
Grafing 11
Southend 11
Stockholm 11
Venezia 11
Washington 11
Auburn Hills 10
Indiana 10
Buffalo 9
Mexico City 9
Pune 9
Warsaw 9
Atlanta 8
Edinburgh 8
Istanbul 8
Laurel 8
Paris 8
Provo 7
Tappahannock 7
Turin 7
Verona 7
Copenhagen 6
Frankfurt am Main 6
Hebei 6
Lappeenranta 6
Las Vegas 6
Leawood 6
Liverpool 6
New Haven 6
Palermo 6
Philadelphia 6
Reggio Emilia 6
San Jose 6
Shanghai 6
Brescia 5
Totale 19.999
Salva come PNG Salva come JPEG
Nome #
What is erythema annulare centrifugum? A familial case 139
Italian translation and validation of fatigue symptoms and impacts questionnaire in relapsing multiple sclerosis (FSIQ-RMS) 121
A mechanism-based classification of pain in multiple sclerosis. 114
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis 113
Ponesimod to treat multiple sclerosis 110
Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis 109
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS 108
Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosis 107
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis 103
Natalizumab treatment in multiple sclerosis: the experience of S. Andrea MS Centre in Rome 99
6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta. 97
Assessing the neurophysiological effects of cannabinoids on spasticity in Multiple Sclerosis 97
Involvement of the limbic system in multiple sclerosis patients with depressive disorders 94
Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis 92
Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis 92
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 92
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis 92
A longitudinal fMRI study on motor activity in patients with multiple sclerosis 92
Effect of corpus callosum damage on ipsilateral motor activation in patients with multiple sclerosis. a functional and anatomical study 91
Psychosocial issue in children and adolescents with multiple sclerosis 90
Treating multiple sclerosis with fingolimod or intramuscular interferon 90
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy 90
Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial 89
The relationship between infratentorial lesions, balance deficit and accidental falls in multiple sclerosis 89
Anatomical and functional correlates of cognitive deficit in multiple sclerosis. 89
Functional connectivity changes and their relationship with clinical disability and white matter integrity in patients with relapsing-remitting multiple sclerosis 89
CEREBROSPINAL FLUID ISOPROSTANES ARE NOT RELATED TO INFLAMMATORY ACTIVITY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS. 89
Diffusion-weighted Imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations 89
Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis: A Double-Blind, Placebo Controlled, Crossover Study. 88
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis. An Italian, Multicenter, Real-World Study 88
Cesarean section in women with MS: A choice or a need? 88
A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis 87
Depression in the early phase of MS: influence of functional disability, cognitive impairment and brain abnormalities. 87
Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 87
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications fro phase II clinical trials. 85
MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS) 85
Effect on cognition of estroprogestins combined with Interferon Beta in multiple sclerosis: analysis of secondary outcomes from a randomised controlled trial 85
Supportive strategies to improve adherence to IFN beta-1b in Multiple Sclerosis - Results of the BetaPlus observational cohort study 85
Clinical measures of disease activity in multiple sclerosis 84
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. 83
Assessing response to interferon-β in a multicenter dataset of patients with MS 83
Cesarean section in women with MS: a choice or a need? 83
Balance deficit with opened or closed eyes reveals involvement of different structures of the central nervous system in multiple sclerosis. 83
Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis. 82
From high- to low-frequency administered interferon-beta for multiple sclerosis: A multicenter study 82
MRI for monitoring response to preventive treatment in multiple sclerosis. 82
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 82
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in relapsing-remitting Multiple sclerosis. an Italian real-word multicenter experience 82
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 82
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: The Italian experience 81
Mesial temporal cortex hypoperfusion is associated with depression in subcortical stroke 81
"Gender Gap" in multiple sclerosis: magnetic resonance imaging evidence. 81
Bacille calmette guerin (BCG) vaccine in multiple sclerosis (MS): A single crossover study 81
determinant spreading without disease progression in multiple sclerosis 81
Long-term safety and efficacy of teriflunomide 81
Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study. 81
Alexithymia in multiple sclerosis: relationship with fatigue and depression 81
Global immune disregulation in multiple sclerosis: from the adaptive response to the innate immunity 80
A controlled study of potential risk factors preceding exacerbation in multiple sclerosis. 80
Development of neutralizing antibodies in patients treated with IFN beta 1a 80
Dentate nucleus connectivity in adult patients with multiple sclerosis: functional changes at rest and correlation with clinical features 80
The pharmacovigilance program on natalizumab in Italy: 2 years of experience. 80
Development of Neutralizing Antibodies in Patients with Relapsing-Remitting Multiple Sclerosis Treated with IFN-β1a 79
Antinuclear antibodies and MRI activity in multiple sclerosis. 79
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 79
Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine. 79
MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis. 78
Corticosteroids treatment 78
Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. 78
Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. 78
Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment 78
Assessing walking disability in multiple sclerosis 76
Cognitive and psychosocial features of childhood and juvenile MS 76
Pulse monthly steroids during an elective interruption of natalizumab: A post-marketing study 76
Cannabinoid-induced effects on the nociceptive system: A neurophysiological study in patients with secondary progressive multiple sclerosis 76
Gray- and White-Matter Changes 1 Year after First Clinical Episode of Multiple Sclerosis: MR Imaging 76
Influence of nimodipine on cerebral blood flow in human cerebral ischaemia. 75
Advances in the management of multiple sclerosis spasticity: Experiences from recent studies and everyday clinical practice 75
A controlled trial of mitoxantrone in multiple sclerosis: serial MRI evaluation at one year. 75
Transcranial Doppler Ultrasonography and Single Photon Emission Tomography following Cerebral Infarction 75
The use of ID migraine (TM) questionnaire in patients with multiple sclerosis 75
Peripheral white blood cell count in cerebral ischemic infarction. 75
Power spectrum analysis contribution to the detection of cardiovascular dysautonomia in multiple sclerosis. 74
Multiple Sclerosis: White and Gray Matter Damage Associated with Balance Deficit Detected at Static Posturography 74
Role of cerebellar dentate functional connectivity in balance deficits in patients with multiple sclerosis 74
A comparison of the sensitivity of monthly unenhanced and enhanced MRI techniques in detecting new multiple sclerosis lesions. 74
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity 74
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis 74
The Impact of Interferon Beta and Natalizumab on Comorbid Migraine in Multiple Sclerosis 74
Tp-Te interval predicts heart rate reduction after fingolimod administration in patients with multiple sclerosis 74
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials 73
Cortical motor reorganization after a single clinical attack of multiple sclerosis 73
Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial 73
Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis. 73
Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis 73
Acetazolamide effects on cerebral blood flow in acute reversible ischemia. 73
A controlled trial of mitoxantrone in multiple sclerosis: serial MRI evaluation at one year. 73
Fingolimod vs dimethyl fumarate in multiple sclerosis. a real-world propensity score-matched study 73
Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine 72
Determinants of the severity of comorbid migraine in multiple sclerosis 72
Totale 8.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.541
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.239 0 0 0 0 0 807 896 806 717 500 296 217
2020/20212.168 255 287 107 148 122 106 204 230 226 242 165 76
2021/20225.053 97 256 459 147 732 205 95 518 373 357 816 998
2022/20234.959 1.063 951 192 477 584 571 63 273 471 63 198 53
2023/20242.091 146 300 72 144 136 241 59 155 26 326 256 230
2024/20251.919 253 288 304 276 352 446 0 0 0 0 0 0
Totale 27.464